These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23146065)

  • 1. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy.
    Lungu C; Considine E; Zahir S; Ponsati B; Arrastia S; Hallett M
    Eur J Neurol; 2013 Mar; 20(3):515-518. PubMed ID: 23146065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
    Mitsikostas DD; Dekundy A; Hanschmann A; Althaus M; Scheschonka A; Pagan F; Jankovic J
    Curr Med Res Opin; 2021 Oct; 37(10):1761-1768. PubMed ID: 34384301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm.
    Sung Y; Nam SM; Lew H
    Korean J Ophthalmol; 2015 Apr; 29(2):115-20. PubMed ID: 25829828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A therapy for blepharospasm.
    Duarte GS; Rodrigues FB; Marques RE; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004900. PubMed ID: 33211907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery.
    Trinchillo A; Cuomo N; Habetswallner F; Esposito M
    Parkinsonism Relat Disord; 2024 Feb; 119():105958. PubMed ID: 38118281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
    Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
    J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
    Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
    J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial.
    Mitsikostas DD; Dekundy A; Sternberg K; Althaus M; Pagan F
    Adv Ther; 2020 Oct; 37(10):4249-4265. PubMed ID: 32779096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of botulinum toxin type a after topical anesthesia.
    Sami MS; Soparkar CN; Patrinely JR; Hollier LM; Hollier LH
    Ophthalmic Plast Reconstr Surg; 2006; 22(6):448-52. PubMed ID: 17117100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
    Lee S; Park S; Lew H
    Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm.
    Wabbels B; Reichel G; Fulford-Smith A; Wright N; Roggenkämper P
    J Neural Transm (Vienna); 2011 Feb; 118(2):233-9. PubMed ID: 21161715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
    Ferrazzano G; Conte A; Fabbrini G; Bologna M; Macerollo A; Defazio G; Hallett M; Berardelli A
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):336-40. PubMed ID: 24963123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI; Shin HM; Lee SY; Lew H
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.
    Jankovic J; Comella C; Hanschmann A; Grafe S
    Mov Disord; 2011 Jul; 26(8):1521-8. PubMed ID: 21520284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tan B; Jia L
    Stroke; 2021 Dec; 52(12):3759-3767. PubMed ID: 34470492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary zinc and phytase supplementation on botulinum toxin treatments.
    Koshy JC; Sharabi SE; Feldman EM; Hollier LH; Patrinely JR; Soparkar CN
    J Drugs Dermatol; 2012 Apr; 11(4):507-12. PubMed ID: 22453589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
    Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
    JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.